Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
The ESMO Deep Dive Webinar: Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) is a specialized oncology program scheduled for June 17, 2026, at 18:30 CEST. Chaired by Professor Silke Gillessen, […]
The ESMO Gynaecological Cancers Congress 2026 will take place from 17–19 June in Copenhagen, Denmark, as well as online. This global event brings together experts, researchers, and healthcare professionals to […]
The ESMO Advanced Course on the Management of Diffuse Large B-Cell Lymphoma (DLBCL) is a specialized, multi-day educational program taking place in Singapore from June 19–20, 2026. Co-chaired by Professor […]
The ESMO Guidelines: Real World Cases - Webinar Series: Cervical Cancer 2026 is a virtual scientific session scheduled for June 24, 2026. Chaired by Ana Oaknin, the webinar is designed […]
The ESMO Preceptorship on Small Cell Lung Cancer (SCLC) 2026 is an advanced educational medical program taking place in Lisbon, Portugal, from June 24–25, 2026. Co-chaired by Dr. Kersti Oselin […]
The ESMO Preceptorship on Gastric Cancer 2026 is a specialized educational event scheduled to take place in Lisbon, Portugal, from June 26–27, 2026. Co-chaired by Tania Fleitas and Hanneke van […]
The ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026 is a virtual webinar scheduled for July 1, 2026, at 18:30 CEST. Chaired by Aurelius Gabriel Omlin, the session […]
The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland. This intensive program is designed to provide medical oncologists with […]
The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich, Germany, and online. This major event brings together global experts, researchers, and healthcare professionals […]
The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed […]
ESMO Preceptorship on Breast Cancer 2026 will take place from 10 Jul 2026 to 11 Jul 2026 in Munich, Germany, under the leadership of Co-Chairs Nadia Harbeck (Munich, Germany) and […]
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by […]
The ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place on 29 July 2026 at 18:30 CEST. The session will use a real-world case to explore current ESMO recommendations for rectal cancer, including multimodality treatment, total neoadjuvant therapy, organ preservation, surgical strategies, […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
